Genomelink
Berkeley
About Genomelink
Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and lead bioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: genomelink.io
- Phone: [email protected]
Industries & Categories
Biotechnology, Consumer Software, Fitness, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/genomelink-38786 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.